CWM
REGN icon

Centricity Wealth Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Centricity Wealth Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$49.4K Hold
94
– – 0.04% 172
2025
Q1 		$59.6K Hold
94
– – 0.05% 151
2024
Q4 		$67K Buy
+94
New +$78.9K 0.06% 140

Other funds holding REGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Centricity Wealth Management's REGN Position: Q2 2025 in Review

Centricity Wealth Management held its Regeneron Pharmaceuticals (REGN) position steady in Q2 2025 at 94 shares worth $49.4K. The position accounts for 0.04% of the portfolio, ranked #172.

Centricity Wealth Management first reported a position in REGN in Q4 2024 and has held it in 3 quarters since. The position peaked at $67K in Q4 2024. 1,202 funds tracked by Wall St. Rank hold REGN as of Q2 2025.

  • Centricity Wealth Management held 94 shares of Regeneron Pharmaceuticals worth $49.4K as of Q2 2025.
  • Centricity Wealth Management left its Regeneron Pharmaceuticals share count unchanged in Q2 2025.
  • Regeneron Pharmaceuticals made up 0.04% of Centricity Wealth Management's portfolio in Q2 2025, its #172 holding.
  • Centricity Wealth Management first reported a position in Regeneron Pharmaceuticals in Q4 2024 and has held it in 3 quarters since.
  • Centricity Wealth Management's Regeneron Pharmaceuticals position peaked at $67K in Q4 2024.
  • 1,202 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2025.

Based on Centricity Wealth Management's 13F filing for Q2 2025, filed 18 Jul 2025.